JPRN-UMIN000014339招募中未知
Phase I/II study of S-1, irinotecan plus oxaliplatin combination therapy (SOXIRI) for advanced pancreatic cancer(KANAPS 06 study) - Phase I/II study of SOXIRI for advanced pancreatic cancer(KANAPS 06 study)
KANAPS(Kansai and Nara Pancreatobiliary Study group)0 个研究点目标入组 53 人开始时间: 2014年6月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 53
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Grade 2 or greater peripheral neuropathy 2) Having UGT1A1*6/*6, UGT1A1*28/*28, or UGT1A1*6/*28 gene 3) Moderate ascites 4)Intestinal pneumonitis or pulmonary fibrosis 5) Uncontrollable diarrhea 6) Serious complications (organ failure, uncontrolled diabetes mellitus, active infection, ulcer, ileus, mental disorders, or central nervous system disorders) 7) Active double cancer 8) Pregnancy 9)Inappropriate for this study judged by the attending physician
研究者
相似试验
招募中
1 期
Phase I study of S-1, irinotecan plus oxaliplatin combination therapy (S-IROX) for advanced pancreatic cancerpancreatic cancerJPRN-UMIN000012054ational Cancer Center Hospital24
已完成
不适用
Phase I study of irinotecan, S-1 and oxaliplatin in combination with radiation therapy in patients with advanced rectal canceradvanced rectal cancerJPRN-UMIN000017674Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine12
已完成
不适用
Phase II study of S-1 combined with irinotecan in patients with advanced colorectal cancerJPRN-UMIN000001741Showa University School of Medicin40
已完成
2 期
A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric CancerStomach NeoplasmsNCT00512681National Cancer Center, Korea44
已完成
2 期
Phase II study of S-1 plus irinotecan combined with biweekly cetuximab as 2nd-line chemotherapy in patients with wild type KRAS unresectable colorectal cancer, who had previously received oxaliplatin-based chemoterapy without CV port. (FUTURE 1103 STUDY)Colorectal CancerJPRN-UMIN000006823Fukuoka Tumor Research(FUTURE)30